Betaine

Suppliers

Names

[ CAS No. ]:
107-43-7

[ Name ]:
Betaine

[Synonym ]:
(Carboxymethyl)trimethylammonium inner salt Oxyneurine
2-N,N,N-trimethylammonio acetate
rubrinec
MFCD00012123
EINECS 203-490-6
OXYNEURINE
(Carboxymethyl)trimethylammonium inner salt
Additive Screening
jortaine
BET
Betain
trimethylammonioacetate
Aminocoat
(Carboxymethyl)trimethylammonium inner salt,Oxyneurine
Betaine
Abromine
LYCINE
wolfberry Extract
trimethylglycine

Chemical & Physical Properties

[ Density]:
1.00 g/mL at 20 °C

[ Melting Point ]:
301-305 °C (dec.)

[ Molecular Formula ]:
C₅H₁₁NO₂

[ Molecular Weight ]:
117.146

[ Exact Mass ]:
117.078979

[ PSA ]:
40.13000

[ LogP ]:
-3.25

[ Storage condition ]:
2-8°C

[ Stability ]:
Stable. Hygroscopic. Incompatible with strong oxidizing agents.

[ Water Solubility ]:
160 g/100 mL

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :: DS5900000

CHEMICAL NAME :: Betaine

CAS REGISTRY NUMBER :: 107-43-7

BEILSTEIN REFERENCE NO. :: 3537113

LAST UPDATED :: 199701

DATA ITEMS CITED :: 3

MOLECULAR FORMULA :: C5-H11-N-O2

MOLECULAR WEIGHT :: 117.17

WISWESSER LINE NOTATION :: QV1K1&1&1 &Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 10800 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Behavioral - fluid intake Lungs, Thorax, or Respiration - cyanosis

REFERENCE :: ABMGAJ Acta Biologica et Medica Germanica. (Berlin, Ger. Dem. Rep.) V.1-41, 1958-82. For publisher information, see BBIADT. Volume(issue)/page/year: 3,28,1959

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 830 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: MPHEAE Medicina et Pharmacologia Experimentalis. (Basel, Switzerland) V.12-17, 1965-67. For publisher information, see PHMGBN. Volume(issue)/page/year: 16,529,1967

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
R20/21/22

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ RTECS ]:
DS5900000

[ HS Code ]:
2923900090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

Chloroacetic acid
Trimethylamine
choline
Betaine Aldehyde Chloride
Choline chloride
Glycine
methyl iodide
(2-acetoxyethyl)trimethylammonium
trimethyl-(2-oxoethyl)ammonium
Dimethyl sulfate

DownStream

methylamine
Ammonia
Dimethylamine
Trimethylamine
TMEDA
D-methionine
Benzaldehyde
Ac-Gly-OH
(2-methoxy-2-oxoethyl)-trimethylazanium,iodide
dms

Customs

[ HS Code ]: 2923900090

[ Summary ]:
2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0%

Articles

The fused anthranilate synthase from Streptomyces venezuelae functions as a monomer.

Mol. Cell Biochem. 400(1-2) , 9-15, (2015)

Recently, we showed that the fused chorismate-utilizing enzyme from the antibiotic-producing soil bacterium Streptomyces venezuelae is an anthranilate synthase (designated SvAS), not a 2-amino-2-deoxy...

Rectification of impaired adipose tissue methylation status and lipolytic response contributes to hepatoprotective effect of betaine in a mouse model of alcoholic liver disease.

Br. J. Pharmacol. 171(17) , 4073-86, (2014)

Overactive lipolysis in adipose tissue contributes to the pathogenesis of alcoholic liver disease (ALD); however, the mechanisms involved have not been elucidated. We previously reported that chronic ...

Generation and characterization of a murine model of Bietti crystalline dystrophy.

Invest. Ophthalmol. Vis. Sci. 55(9) , 5572-81, (2014)

Bietti crystalline dystrophy (BCD) is a rare, autosomal recessive, progressive, degenerative eye disease caused by mutations in the CYP4V2 gene, for which no treatments are currently available. Cyp4v3...